Laboratory screening markers are used in medical laboratories to identify certain conditions or diseases. They can also be used to monitor the progression of a disease or treatment. Screening markers are typically proteins that are found in blood or other bodily fluids and are used to detect the presence of a certain disease or condition. Screening markers can be used to detect a wide range of conditions, including cancer, heart disease, diabetes, and infectious diseases. They can also be used to screen for genetic disorders, such as cystic fibrosis, Huntington’s disease, and sickle cell anaemia. Screening markers are usually measured using an ELISA (enzyme-linked immunosorbent assay) or PCR (polymerase chain reaction). ELISAs measure the amount of a particular antigen present in a sample, while PCR detects the presence of a specific gene. The accuracy of screening markers depends on the technique used and the sensitivity of the test. Generally, screening markers are very accurate and can detect even small amounts of the antigen or gene in question. Screening markers are an important tool in the diagnosis of many conditions and diseases. They can provide a quick, reliable result and can help to rule out or confirm a diagnosis.
Title : Early and late evaluation of esophageal mucosectomy in surgical treatment of advanced esophageal achalasia
Jose Luis Braga De Aquino, Pontifical Catholic University of Campinas, Brazil
Title : How epigastric impedance would radically change gastric medicine
John Andrew Sutton, Invention City, United States
Title : Nanoemulsions as a strategy to enhance gastrointestinal bioavailability and bioactivity of lipid based nutraceuticals
Pubali Dhar, University of Calcutta, India
Title : Professional dining and health
Yaffa Machnes, Bar-Ilan University, Israel
Title : Sickle cell liver disease: A multidisciplinary hemato-hepatology approach
Bandar Aljudaibi, King Faisal Specialists Hospital and Research Centre, Saudi Arabia
Title : From the birth of atoms to life: Iodine and caesium, angels and demons of evolutionary biology, in pancreatic cancer and diabetes
Venturi Sebastiano, Department of Public Health of Romagna, Italy